Skip to main content

Dihexa vs Ipamorelin

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Dihexa

Dihexa is a nootropic peptide derived from angiotensin IV. It has shown remarkable cognitive-enhancing properties in animal studies, being described as potentially millions of times more potent than BDNF.

Full details →

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that stimulates the release of growth hormone from the pituitary gland without significantly affecting cortisol or prolactin.

Full details →

Side-by-Side Comparison

AspectDihexaIpamorelin
MechanismActs as a hepatocyte growth factor (HGF) potentiator by binding to its receptor c-Met. Promotes synaptogenesis, neuronal survival, and cognitive enhancement through this pathway.Acts as a ghrelin mimetic, binding to the ghrelin receptor (GHS-R) in the pituitary to stimulate GH release. Highly selective with minimal effect on other hormones.
Typical DosageResearch dosing is highly variable due to extreme potency. Typical range: 10-40mg orally or sublingually. Start with lowest doses due to potency.Typical dosing ranges from 200-300mcg administered 2-3 times daily, often combined with CJC-1295.
AdministrationCan be taken orally, sublingually, or intranasally. Extremely potent - careful dosing is essential. Best used cyclically.Subcutaneous injection. Best results when administered fasted or before sleep. Often stacked with GHRH peptides.
Side EffectsLimited human data. Reported effects include headache, temporary brain fog during adjustment, and potential mood changes.Generally well-tolerated. May cause mild headaches, lightheadedness, or increased hunger initially.
Best For

Key Differences

Detailed Analysis

Dihexa and Ipamorelin are used for different purposes and have limited overlap in their applications.

Which Should You Choose?

Choose Dihexa for Cognitive Performance. Choose Ipamorelin for Muscle Growth, Fat Loss, Recovery & Healing, Sleep Quality.

Ready to Learn More?